ProUroCare Medical

ProUroCare Medical FCF Margin

Free Cash Flow Margin of ProUroCare Medical (PUMD) as of Oct 20, 2026.

FCF Margin

-

Last updated:

Free Cash Flow Margin of ProUroCare Medical is 2026 - . Free Cash Flow Margin of ProUroCare Medical was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ProUroCare Medical Stock analysis

What does ProUroCare Medical do? ProUroCare Medical Inc, based in Eden Prairie, US, develops medical devices for prostate disease detection and characterization. The company focuses on the ProUroScan System, an imaging device that creates real-time elasticity images of the prostate using a rectal probe and specialized software. This system aids in visualizing abnormalities detected during digital rectal exams, offering two- and three-dimensional imaging capabilities. With a small team of two employees, ProUroCare operates in the Health Care sector, specializing in diagnostic tools for prostate health. ProUroCare Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ProUroCare Medical stock

On Eulerpool you can find the complete historical development of Free Cash Flow Margin ProUroCare Medical since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's ProUroCare Medical with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — ProUroCare Medical

All Key Metrics — ProUroCare Medical